Clinical value of epidermal growth factor receptor mutation testing in peripheral blood of patients with non-small cell lung cancer
EGFR mutation in peripheral blood and tumor tissues is highly consistent in NSCLC patients. The EGFR mutation rate is higher in adenocarcinoma and non-smoking patients, and the prognosis is better in patients with EGFR mutations.
Authors
- Xiaomeng Zheng
- Yanan Meng
- Xiaodan Liu (ORCID: https://orcid.org/0000-0002-9796-8215)
- Xiaodong Li (ORCID: https://orcid.org/0000-0002-9394-1082)
- Chengbi Tong
Institutions
- Affiliated Hospital of Hebei University (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-11-21
- DOI
- https://doi.org/10.12669/pjms.40.11.9564
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Hebei Province
- Hebei University